Decoding the genetic and environmental forces in propelling the surge of early-onset colorectal cancer

Abstract

Early-onset colorectal cancer (EOCRC) shows a different epidemiological trend compared to later-onset colorectal cancer, with its incidence rising in most regions and countries worldwide. However, the reasons behind this trend remain unclear. The etiology of EOCRC is complex and could involve both genetic and environmental factors. Apart from Lynch syndrome and Familial Adenomatous Polyposis, sporadic EOCRC exhibits a broad spectrum of pathogenic germline mutations, genetic polymorphisms, methylation changes, and chromosomal instability. Early-life exposures and environmental risk factors, including lifestyle and dietary risk factors, have been found to be associated with EOCRC risk. Meanwhile, specific chronic diseases, such as inflammatory bowel disease, diabetes, and metabolic syndrome, have been associated with EOCRC. Interactions between genetic and environmental risk factors in EOCRC have also been explored. Here we present findings from a narrative review of epidemiological studies on the assessment of early-life exposures, of EOCRC-specific environmental factors, and their interactions with susceptible loci. We also present results from EOCRC-specific genome-wide association studies that could be used to perform Mendelian randomization analyses to ascertain potential causal links between environmental factors and EOCRC.

Keywords: Early-onset colorectal cancer; Environmental factors; Genetic factors; Genome-wide association study; Germline variants; Interaction; Lifestyle.

Figure 1

Environmental factors related to early-onset colorectal cancer. DM: Diabetes mellitus; EOCRC: Early-onset colorectal cancer; IBD: Inflammatory bowel disease; MS: Metabolic syndrome; NSAIDs: Non-steroidal anti-inflammatory drugs.

Figure 2

Genetics of early-onset colorectal cancer and its interaction with environmental factors. EOCRC: Early-onset colorectal cancer; FAP: Familial adenomatous polyposis; NSAIDs: Non-steroidal anti-inflammatory drugs.